28822-58-4

IBMX has been shown to be a potent, non-specific inhibitor of adenosine 3′,5′-cyclic monophosphate phosphodiesterase (cAMP PDE)4, significantly more effective than theophylline. Also inhibits cGMP phosphodiesterases. IBMX inhibits cyclic nucleotide PDE with subsequent inhibition of cyclic nucleotide hydrolysis, resulting in accumulation of cyclic AMP and guanosine 3′,5′-cyclic monophosphate.

IBMX has been shown to be a potent, non-specific inhibitor of adenosine 3′,5′-cyclic monophosphate phosphodiesterase (cAMP PDE)4, significantly more effective than theophylline. Also inhibits cGMP phosphodiesterases. IBMX inhibits cyclic nucleotide PDE with subsequent inhibition of cyclic nucleotide hydrolysis, resulting in accumulation of cyclic AMP and guanosine 3′,5′-cyclic monophosphate.

IBMX has been shown to be a potent, non-specific inhibitor of adenosine 3′,5′-cyclic monophosphate phosphodiesterase (cAMP PDE)4, significantly more effective than theophylline. Also inhibits cGMP phosphodiesterases. IBMX inhibits cyclic nucleotide PDE with subsequent inhibition of cyclic nucleotide hydrolysis, resulting in accumulation of cyclic AMP and guanosine 3′,5′-cyclic monophosphate.

IBMX has been shown to be a potent, non-specific inhibitor of adenosine 3′,5′-cyclic monophosphate phosphodiesterase (cAMP PDE)4, significantly more effective than theophylline. Also inhibits cGMP phosphodiesterases. IBMX inhibits cyclic nucleotide PDE with subsequent inhibition of cyclic nucleotide hydrolysis, resulting in accumulation of cyclic AMP and guanosine 3′,5′-cyclic monophosphate.

Molecular Formula : C10 H14 N4 O2

Molecular Formula : C10 H14 N4 O2

IBMX

IBMX